LRCX
43
-2
PSA
58
2
NOC
43
11
TJX
64
2
USB
55
-6
IR
66
3
DD
63
3
MTB
67
2
AXP
71
2
AVY
53
3
EFX
38
2
PGR
65
2
NVDA
56
-4
WY
54
4
SYK
64
-4
GOOG
50
-3
M
37
12
WU
32
2
XRX
44
3
HON
67
2
LRCX
43
-2
PSA
58
2
NOC
43
11
TJX
64
2
USB
55
-6
IR
66
3
DD
63
3
MTB
67
2
AXP
71
2
AVY
53
3
EFX
38
2
PGR
65
2
NVDA
56
-4
WY
54
4
SYK
64
-4
GOOG
50
-3
M
37
12
WU
32
2
XRX
44
3
HON
67
2
Financhill
Back

MoonLake Immunotherapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
77

MLTX
MoonLake Immunotherapeutics

Last Price:
54.25
Seasonality Move:
43.17%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

MoonLake Immunotherapeutics Price Quote

$54.25
-0.07 (4.61%)
(Updated: November 23, 2024 at 5:44 AM ET)

MoonLake Immunotherapeutics Key Stats

Buy
77
MoonLake Immunotherapeutics (MLTX) is a Buy
Day range:
$51.43 - $54.93
52-week range:
$37.55 - $64.98
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
7.02%
Volume:
223.4K
Avg. volume:
221.1K
1-year change:
19.89%
Market cap:
$3.4B
Revenue:
$0
EPS:
$-1.27

How Much Does MoonLake Immunotherapeutics Make?

Data Unavailable

Is MoonLake Immunotherapeutics Growing As A Company?

Data Unavailable

MoonLake Immunotherapeutics Stock Price Performance

What Is MoonLake Immunotherapeutics 52-Week High & Low?

MoonLake Immunotherapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy MoonLake Immunotherapeutics?

Is MoonLake Immunotherapeutics Cash Flow Positive?

  • What Is MLTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$80.5M
  • What Is MoonLake Immunotherapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $79.6M
  • What Is MoonLake Immunotherapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $58.6M

MoonLake Immunotherapeutics Return On Invested Capital

Data Unavailable

MoonLake Immunotherapeutics Earnings Date & Stock Price

MoonLake Immunotherapeutics Competitors

MoonLake Immunotherapeutics Dividend Yield

MoonLake Immunotherapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -23.33%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 73.92
Upside from Last Price: 36.09%

Major Shareholders

  • How many MLTX shares are owned by institutional investors?
    99.9M MLTX shares are owned by institutional investors
  • How many MLTX shares are owned by insiders?
    3.7M MLTX shares are owned by insiders